Table 2. Effects of siRNA 6 on hFIX expression from HepG2 cells transfected with -416FIXm1 (containing no AIE) and -416FIXm1/1.4 (containing AIE).
Relative expression Activity (% ± SD)* | |||
siRNA | MOI | -416FIIX m1 | -416FIIX m1/1.4 |
PBS-saline | 100 | 100 | |
Scrambled siRNA 6 | 2 | 105±16 | 100±17 |
siRNA 6 | 2 | 109±17 | 96±9 |
Scrambled siRNA 6 | 20 | 100±15 | 98±6 |
siRNA 6 | 20 | 109±21 | 86±23 |
Scrambled siRNA 6 | 100 | 108±23 | 98±16 |
siRNA 6 | 100 | 104±25 | 64±21# |
*HepG2 cells transfected with hFIX minigene expression vector, -416FIXm1 (containing no AIE) or -416FIXm1/1.4 (containing AIE), were treated with PBS-saline, or transduced with adenoviral particles harboring scrambled siRNA 6 or siRNA 6, and hFIX protein produced was measured (n = 4). Human FIX expression activity was normalized to that of HepG2 cells treated with PBS-Saline for each expression vector condition. SD, standard deviation. #P<0.05 (vs. scrambled siRNA6).